AXT stock has delivered a very large 1 year gain while the valuation checks suggest the shares are now pricing in a lot of optimism rather than offering a clear bargain.

• AXT has returned about 17x over the past year, which puts extra focus on whether the current price still lines up with the company’s fundamentals.
• Heavy investment to expand indium phosphide capacity for AI data center demand can support long term revenue potential. However, the sizeable capital raise and listing shift for its Tongmei subsidiary add execution and financing risk that could affect how investors think about fair value.
• With the stock passing only 2 of 6 valuation checks, AXT currently leans expensive rather than looking like an obvious value opportunity.

The issue now is whether AXT’s rapid share price rise is justified by its fundamentals or has moved ahead of what the business can reasonably support.

Is AXT Getting Expensive on Sales?

The P/S multiple is a useful lens for AXT because the focus is currently on revenue potential from indium phosphide capacity rather than on earnings.

AXT trades on a P/S of about 30.3x, which is far above the semiconductor industry average of 7.2x and the peer group at roughly 3.8x. The model based on the company’s growth profile, margins, size and risks points to a fair P/S ratio closer to 18.1x, so the current market price implies a substantial premium to what that framework suggests.

Despite the recent AI related contract wins and capital raise lifting interest in AXT stock, the current P/S multiple still prices the company well ahead of sector norms and the modelled fair ratio. This indicates that investors are paying a high price for AXT’s revenue prospects, with limited room for disappointment built into the sales multiple.

On the P/S yardstick, AXT stock currently appears overvalued compared with both its industry and the modelled fair multiple.

The AXT Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where the AXT valuation puzzle leaves off by spelling out which combinations of growth, margins and earnings would need to hold for AXT's stock to be worth materially more or less than it is today. Each Narrative presents fair value as a thesis about AXT's business that readers can revisit over time, and they appear on Simply Wall St's Community page for further context and discussion.

One of the top community narratives on AXT: 64% undervalued

"Vertical integration and a potential Tongmei IPO could drive financial resilience, hidden value realization, and improved competitive positioning..."

Do you think there's more to the story for AXT? Head over to our Community to see what others are saying!

The Bottom Line

AXT now trades on a market multiple that screens as overvalued, with investors clearly paying up for its revenue story rather than getting an obvious discount. After such a sharp 1 year move, the key question is whether the growth and margin profile that would justify this richer P/S actually materialises, especially given the capital needs and execution risks around Tongmei. For many investors, the crux from here is simple: whether AXT can turn capacity expansion and AI related demand into durable, profitable sales fast enough to support the current valuation, or whether sentiment cools before the fundamentals catch up.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.